September 2, 2014 POET Technologies and Synopsys

New Post Public Reply Private Reply Replies (1) Message Board
sevenOdouble 11072017 #36935
September 2, 2014
POET Technologies and Synopsys Collaborate on Advanced Modeling of Planar Electrical Technology and Development of POET's First Process Design Kit
TORONTO, ONTARIO and STORRS, CONNECTICUT--(Marketwired - Sept. 2, 2014) - POET Technologies Inc. (TSX VENTURETK)(OTCQXOETF) ("the Company" - developer of the planar opto-electronic technology (POET) platform for monolithic fabrication of integrated circuit devices containing both electronic and optical elements on a single semiconductor wafer - today announced a collaboration with Synopsys, Inc. -- a global leader providing software, IP and services used to accelerate innovation in chips and electronic systems -- to develop an advanced model and first Process Design Kit (PDK) of POET's electrical devices (PET) targeting the 40-nm technology node widely used for highly integrated systems-on-chip (SoC).

Through this collaboration, POET Technologies will use Synopsys' TCAD toolset and services to continue to develop the PET and POET PDKs. The PET PDK milestone (MS-12) focuses on devices requiring only the electronic subset of the POET devices and processes. Mr. Daniel DeSimone, CTO noted: "Synopsys will provide expertise and services to the POET team, enabling us to expedite the design process. The Synopsys TCAD software toolset is well positioned for the POET PDK requirements."

The Synopsys toolset will be used for process technology development and design of nano-scale devices in POET's III-V compound semiconductor process. Devices include complementary HFET and HBT transistors with high electron mobility performance, including a thyristor with both optical and electrical operation. These devices will form the foundation of POET's technology that is able to integrate active optical circuitry, lasers, modulators, filters, detectors and electrical circuitry on a single die.

"POET Technologies III-V process and devices IP represent a significant innovation for our industry, and we look forward to the opportunity to work with the POET team on their first PDK," said Terry Ma, Vice President of Engineering for TCAD at Synopsys. "This collaboration with POET will combine the strengths of our TCAD modeling expertise and POET's innovative technologies to provide leading-edge semiconductor companies significant benefits for next-generation semiconductor designs."

The PET PDK and process offers lower cost and simpler process fab options for applications that do not require the full POET optical feature set. Due to the high mobility inherent in III-V materials, PET technology is predicted to deliver performance, which could be equivalent to 3 to 4 nodes ahead of mainstream technologies. Further performance and novel capabilities will be enabled by the incorporation of in-plane optical intra and inter-chip signaling capabilities within the electrical technology. The PET/PDK is scheduled to be available at the end of Q4 2014 and will allow POET to provide detailed design information to industry fab partners and customers. This will enable pre-semiconductor design evaluation to integrate optical, analog and digital functions together. PET-based electronic devices represent a breakthrough in performance and power efficiency.

Mr. Copetti concluded, "We are delighted to target a 40-nm technology node for our first PDK delivery. This is an aggressive target for our POET devices and process IP. This will demonstrate to the industry the significance and the strengths of POET compared to the performance and power efficiency of today's widely used technologies."
Scroll down for more posts ▼

Top 10 Most Recent News Articles

InsCorp's Steady Q3 Climb Mirrors Strategic Focus

Updated Category News Views 46

Riding the Revenue Wave Now we're talking about a bank knowing their business—InsCorp, Inc. recently flaunted a 12% year-on-year revenue bump for 3Q26, a testament to a strategy that's clearly sticking. Still, while those numbers are nice and shiny, the detailed breakdown shows earnings per share (EPS) barely budged from last quarter, coming in at $0.73, just a hair...

Continue Reading
Nanoscope Therapeutics Aims for Eye-Catching Advances

Updated Category News Views 87

Gearing Up for a Boston Showcase Nanoscope's High-Stakes Boston Rendezvous In a move set to grab some serious eyeballs, Nanoscope Therapeutics is geared up to strut their stuff at Advanced Therapies USA 2026 in Boston. Scheduled for November 4–5 at the Hynes Convention Center, the event isn't just another pitstop—it's a billboard for what these guys have cooking. With...

Continue Reading
Kuvings Unveils Hands-Free Juicer for Healthy Living

Updated Category News Views 96

A Fresh Squeeze in the Juice World If you've ever wanted something that makes that morning juice without you running a marathon in your own kitchen, Kuvings might just have the answer with their new AUTO10 SQUARE™ Plus. Announced on October 30, 2026, this isn't just another fancy named gadget—it actually shakes things up with a hands-free design that’s tailored for...

Continue Reading
CMRE Facing Legal Heat Over Wage Allegations

Updated Category News Views 10

Another Day, Another Lawsuit Ah, work. It’s what gets us up in the morning, whether we like it or not. Yet, for many, it can feel more like a dubious hustle when the rewards don't match the effort. Now, CMRE Financial Services, Inc. finds itself under the legal microscope, thanks to a fresh class-action lawsuit filed by the legal eagles at Blumenthal Nordrehaug Bhowmik...

Continue Reading
Lepage Millwork to Acquire Custom Window Maker Fenêtres MQ

Updated Category News Views 64

Big Move in Windows: Lepage Eyes Fenêtres MQ Dust off those old window ledgers, folks, because we've got a shake-up in the custom luxury window game. Lepage Millwork, a family-run titan in the North American fenestration scene, is gearing up to take over Fenêtres MQ from the big shots over at Andersen. We're talking about an ownership shift set to seal the deal by...

Continue Reading
Bybit Unveils Platform Vision at HK FinTech Week

Updated Category News Views 63

Bybit's Strategic Participation at HK FinTech Week Here’s what’s got everyone buzzing: Bybit is stepping onto the big stage at the Hong Kong FinTech Week 2026. We're talking about the crème de la crème of fintech gatherings, where the sharpest minds of the financial world mingle, munch, and strategize under the buzzing neon of Hong Kong. Bybit's involvement is no...

Continue Reading
WHI's Nexus AI Transforms Phone Ordering in Parts Biz

Updated Category News Views 174

Nexus AI: The New Frontline for Part Distributors In a move poised to shake up the auto parts distribution scene, WHI Solutions, a child of eBay, is rolling out a game-changer: the Nexus AI suite designed for the Nexpart platform. Now, tech and tradition blend as AI tackles phone ordering for those early-morning rushes and late-night calls. A Solution for Your Busiest...

Continue Reading
Texas Home Boasts PGA-Caliber Green with Synthetic Turf

Updated Category News Views 40

Swinging for Luxury in Your Backyard Who'd have thought that a chunk of Austin, Texas, could boast a putting green that’s giving any PGA course a run for its money? We’re talking about a family here who decided they’d had enough of scalding summers and winter chills and wanted a taste of that country club glam at home without the upkeep headaches. The Rise of...

Continue Reading
California Housing Affordability Stagnant as Rates Rise

Updated Category News Views 55

Numbers Tell the Story Get this: California's housing market's as sticky as day-old gum on a hot sidewalk. Despite a dip in home prices, affordability just won't budge. The California Association of REALTORS® (C.A.R.) says 19% of households could afford a median-priced home at $894,630, exactly like last quarter and even a year back. Not a flicker of change. Quirky it...

Continue Reading
Endava's Securities Class Action Heats Up Wall Street

Updated Category News Views 13

A Head-Spinning Fall for Endava Endava's recent tumble on the NYSE has investors rubbing their eyes in disbelief. A jaw-dropping 25% slide in share value on September 22, 2026, has everyone scrambling for answers. Looks like some serious skeletons were hiding deep in Endava's closets—management snafus and fuzzy accounting being at the forefront. This debacle has peeled...

Continue Reading

Top 5 Most Recently Viewed Articles

Amendments Approved by Baltic Horizon Fund Bondholders

Updated Category News Views 192

Key Amendments Approved for Baltic Horizon Fund Bonds Baltic Horizon Fund sought the approval of its bondholders for several amendments related to its EUR 42 million floating rate bonds set to mature in 2028. This written procedure occurred recently, allowing bondholders to engage in crucial decisions regarding the terms governing their investments. Voting Procedures and...

Continue Reading
Sagimet Biosciences Shares Exciting First Quarter Highlights

Updated Category News Views 177

Sagimet Biosciences Financial Overview Sagimet Biosciences Inc. (NASDAQ: SGMT), a pioneering clinical-stage biopharmaceutical company, has made waves in the healthcare industry with its innovative approach to combating metabolic dysfunction and fibrotic diseases. Recently, this California-based firm announced their financial results for the first quarter, concluding on...

Continue Reading
Important Class Action for Lilium N.V. Shareholders to Join

Updated Category News Views 107

Class Action Notice for Shareholders of Lilium N.V. (LILMF) The Gross Law Firm has announced a significant action that involves shareholders of Lilium N.V. (LILMF). This notice is particularly important for those who have purchased shares during the specified class period. If you have invested in Lilium, it is crucial to understand the implications of this class action....

Continue Reading
Intellia Launches Pivotal Phase 3 Trial for NTLA-2002

Updated Category News Views 84

Intellia Therapeutics Advances Gene Editing with NTLA-2002 Intellia Therapeutics, Inc. (NASDAQ: NTLA), an innovator in CRISPR-based gene editing therapies, has announced the launch of a pivotal Phase 3 trial for its revolutionary treatment NTLA-2002. This therapy is aimed at addressing hereditary angioedema (HAE), a rare but severe condition that can lead to...

Continue Reading
Margot Black Unveils New Book: Transform Your Dreams Now

Updated Category News Views 120

Margot Black Announces Her Empowering New Book Margot Black's latest guide offers a roadmap for dreamers to achieve real-life results Award-winning publicist, communication strategist, and bestselling author Margot Black is set to inspire readers with her third book, How to Be Your Own Fairy Godmother and Make Your Life Come True. This innovative guide is crafted to...

Continue Reading